While our study specifically investigates genetic mutations in the MAPK and JAK/STAT pathways, we acknowledge that alterations in other pathways, such as the PI3K/AKT/mTOR pathway [39], also play critical roles in colorectal cancer progression. This evidence concerns the gene AKT1 and colorectal cancer.